Skip to main content

Table 5 Value based price for each country

From: Cost effectiveness and affordability of trastuzumab in sub-Saharan Africa for early stage HER2-positive breast cancer

Country

Value based price (1 GDP per capita)

Value based price (3 GDP per capita)

Congo

466

1392

Ethiopia

727

2012

Guinea

591

1659

Kenya

1395

4147

Namibia

5068

14,451

Nigeria

2832

7620

Rwanda

743

2179

Uganda

731

2083

Zambia

1332

3912

Zimbabwe

1139

3109

South Africa

5936

17,728